DOCKING STUDIES OF CURCUMIN AS A POTENTIAL LEAD COMPOUND TO DEVELOP NOVEL DIPEPTYDYL PEPTIDASE-4 INHIBITORS

https://doi.org/10.22146/ijc.21574

Enade Perdana Istyastono(1*)

(1) Leiden/Amsterdam Center for Drug Research (LACDR), Department of Chemistry, Vrije Universiteit Amsterdam De Boelelaan 1083, 1081HV Amsterdam, the Netherlands
(*) Corresponding Author

Abstract


Interaction of curcumin to dipeptydyl peptidase-4 (DPP-4) has been studied by employing docking method using Molecular Operating Environment (MOE) and AutoDock as the docking software applications. Although MOE can sample more conformational spaces that represent the original interaction poses than AutoDock, both softwares serve as valid and acceptable docking applications to study the interactions of small compound to DPP-4. The calculated free energy of binding (DGbinding)results from MOE and AutoDock shows that curcumin is needed to be optimized to reach similar or better DGbinding compare to the reference compound. Curcumin can be considered as a good lead compound in the development of new DPP-4 inhibitor. The results of these studies can serve as an initial effort of the further study.


Keywords


curcumin; docking; molecular operating environment (MOE); AutoDock; dipeptydyl peptidase-4 (DPP-4)

Full Text:

Full Text PDF


References

[1]   Biftu, T., Scapin, G., Singh, S., Feng, D., Becker, J.W., Eiermann, G., He, H., Lyons, K., Patel, S., Petrov, A., Sinha-Roy, R., Zhang, B., Wu, J., Zhang, X., Doss, G.A., Thornberry, N.A., and Weber, A.E., 2007, Bioorg. Med. Chem. Lett., 17 (12), 3384-7.

[2]   Liang, G.B., Qian, X., Biftu, T., Singh, S., Gao, Y.D., Scapin, G., Patel, S., Leiting, B., Patel, R., Wu, J., Zhang, X., Thornberry, N.A., and Weber, A.E., 2008, Bioorg. Med. Chem. Lett., 18 (13), 3706-10.

[3]   Biftu, T., Feng, D., Qian, X., Liang, G.B., Kieczykowski, G., Eiermann, G., He, H., Leiting, B., Lyons, K., Petrov, A., Sinha-Roy, R., Zhang, B., Scapin, G., Patel, S., Gao, Y.D., Singh, S., Wu, J., Zhang, X., Thornberry, N.A., and Weber, A.E., 2007, Bioorg. Med. Chem. Lett., 17 (1), 49-52.

[4]   Drucker, D., Easley, C., and Kirkpatrick, P., 2007, Nat. Rev. Drug. Discov., 6 (2), 109-10.

[5]   Herman, G.A., Stein, P.P., Thornberry, N.A., and Wagner, J.A., 2007, Clin. Pharmacol. Ther., 81 (5), 761-7.

[6]   Pratley, R.E. and Salsali, A., 2007, Curr. Med. Res. Opin., 23 (4), 919-31.

[7]   Thornberry, N.A. and Weber, A.E., 2007, Curr. Top. Med. Chem., 7 (6), 557-68.

[8]   Ahren, B., 2007, Diabetes Care, 30 (6), 1344-50.

[9]   Gadsby, R., 2007, Prim. Care Diabetes, 1 (4), 209-11.

[10] Idris, I. and Donnelly, R., 2007, Diabetes Obes. Metab., 9 (2), 153-65.

[11] Maes, M.B., Dubois, V., Brandt, I., Lambeir, A.M., Van der Veken, P., Augustyns, K., Cheng, J.D., Chen, X., Scharpe, S., and De Meester, I., 2007, J. Leukoc. Biol., 81 (5), 1252-7.

[12] Sutanegara, D. and Budhiarta, A.A., 2000, Diabetes. Res. Clin. Pract., 50 Suppl 2, S9-S16.

[13] Alarcon de la Lastra, C., 2008, Mol. Nutr. Food. Res., 52 (9), 985.

[14] Mangestuti, Subehan, Widyawaruwanti, A., Zaidi, S.F.H., Awale, S., and Kadota, S., 2007, J. Trad. Med., 24, 90-103.

[15] Sardjiman, Reksohadiprodjo, M.S., Hakim, L., van der Goot, H., and Timmerman, H., 1997, Eur. J. Med. Chem., 32, 625-630.

[16] Reksohadiprojo, M.S., Timmerman, H., Sardjiman, Margono, S.A., Martono, S., Sugiyanto, Hakim, L., Nurlaila, Hakim, A.R., Puspitasari, I., Nurrochmad, A., Purwantiningsih, Oetari, and Tedjo, Y., 2003, Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone, and therapeutic uses thereof, United States Patent Application Publication No.: US2003092772, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta.

[17] Usharani, P., Mateen, A.A., Naidu, M.U., Raju, Y.S., and Chandra, N., 2008, Drugs R. D., 9 (4), 243-50.

[18] Kroemer, R.T., 2007, Curr. Protein. Pept. Sci., 8 (4), 312-28.

[19] Vilar, S., Cozza, G., and Moro, S., 2008, Curr. Top. Med. Chem., 8 (18), 1555-72.

[20] Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., and Olson, A.J., 1998, J. Comp. Chem., 19, 1639-1662.

[21] Sanner, M.F., 1999, J. Mol. Graphics Mod., 17 (57-61).

[22] DeLano, W.L., 2002, The PyMOL User's Manual, DeLano Scientific, Palo Alto, CA, USA.

[23] Matsumoto, M.L., Narzinski, K., Kiser, P.D., Nikiforovich, G.V., and Baranski, T.J., 2007, J. Biol. Chem., 282 (5), 3105-21.

[24] Istyastono, E.P., Margono, S.A., and Pramono, H.D., 2003, Indonesian Journal of Pharmacy, 14 (3), 107-133.

[25] Goodsell, D.S., Morris, G.M., and Olson, A.J., 1996, J. Mol. Recognit., 9 (1), 1-5.

[26] Sousa, S.F., Fernandes, P.A., and Ramos, M.J., 2006, Proteins, 65 (1), 15-26.

[27] Schames, J.R., Henchman, R.H., Siegel, J.S., Sotriffer, C.A., Ni, H., and McCammon, J.A., 2004, J. Med. Chem., 47 (8), 1879-81.

[28] Oprea, T.I., Davis, A.M., Teague, S.J., and Leeson, P.D., 2001, J. Chem. Inf. Comput. Sci., 41 (5), 1308-15.



DOI: https://doi.org/10.22146/ijc.21574

Article Metrics

Abstract views : 516 | views : 546


Copyright (c) 2010 Indonesian Journal of Chemistry

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 


Indonesian Journal of Chemisty (ISSN 1411-9420 / 2460-1578) - Chemistry Department, Universitas Gadjah Mada, Indonesia.

Web
Analytics View The Statistics of Indones. J. Chem.